Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 3, 2011, Pages 445-450

  Shewiyo, D H ^a,b,c   Kaale, E ^b   Ugullum, C ^a   Sigonda, M N ^a   Risha, P G ^b   Dejaegher, B ^c   Smeyers Verbeke, J ^c   Heyden, Y Vander ^c  

^a Tanzania Food and Drugs Authority   (Tanzania)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Densitometry and validation; Lamivudine; Nevirapine; Normal phase HPTLC; Stavudine

Indexed keywords

ACETIC ACID ETHYL ESTER; AMMONIA; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; METHANOL; NEVILAT; NEVIRAPINE; SILICA GEL; STAVUDINE; TOLUENE; TT VIR; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DENSITOMETRY; DRUG STRUCTURE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TABLET FORMULATION; TIME SERIES ANALYSIS; VALIDATION PROCESS;

ANTI-HIV AGENTS; CALIBRATION; CHROMATOGRAPHY, THIN LAYER; DENSITOMETRY; DRUG COMBINATIONS; HUMANS; LAMIVUDINE; NEVIRAPINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAVUDINE; TABLETS;

EID: 78149498909     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.09.009     Document Type: Article

References (22)

1. Kapoor N., Khandavilli S., Panchagnula R. Simultaneous determination of lamivudine, stavudine and nevirapine in antiretroviral fixed dose combinations by high performance liquid chromatography. Anal. Chim. Acta 2006, 570:41-45.
2. Sarasa M., Riba N., Zamora L., Carne X. Determination of stavudine in human plasma and urine by high-performance liquid chromatography using a reduced sample volume. J. Chromatogr. B 2000, 746:183-189.
3. Pereira S.A.S., Kenney K.B., Cohen M.S., Hall J.E., Eron J.J., Tidwell R.R., Dunn J.A. Simultaneous determination of lamivudine and zidovudine concentrations in human plasma using high-performance liquid chromatography and tandem mass spectrometry. J. Chromatogr. B 2000, 742:173-183.
4. Hoetelmans R.M.W., Profijt M., Meenhorst L., Mulder J.W., Beijnen J.H. Quantitative determination of (-) -2'-deoxy-3'-thiacytidine (lamivudine) in human plasma, saliva and cerebrospinal fluid by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 1998, 713:387-394.
5. Hollanders R.M.F., van Ewijk-Beneken Kolmer E.W.J., Burger D.M., Wuis E.W., Koopmans P.P., Hekster Y.A. Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor in human plasma by reversed-phase high-performance liquid chromatography. J. Chromatogr. B 2000, 744:65-71.
6. Rezk N.L., Tidwell R.R., Kashuba A.D.M. Simple and rapid quantification of non-nucleoside reverse transcriptase inhibitors nevirapine, delavirde and efavirenz in human blood plasma using high performance liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B 2002, 774:79-88.
7. Rebiere H., Mazel B., Civade C., Bonnet P.A. Determination of 19 antiretroviral agents in pharmaceutical of suspected products with two methods using high performance liquid chromatography. J. Chromatogr. B 2007, 850:376-383.
8. Sarkar M., Khandavilli S., Panchagulla R. Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms. J. Chromatogr. B 2006, 830:349-354.
9. Basavaiah K., Somashekar B.C., Ramakrishna V., Rapid Titrimetric Spectrophotometric assay methods for the determination of lamivudine in pharmaceuticals using iodate and two dyes. J. Anal. Chem. 2007, 62:542-548.
10. Kaul N., Agrawal H., Paradkar A.R., Mahadik K.R. The international conference on harmonisation guidance in practice: Stress degradation studies on lamivudine and development of a validated specific stability-indicating HPTLC assay method. Chromatographia 2004, 60:213-221.
11. Habte G., Hymete A., Mohamed A.M.I. Simultaneous separation and determination of lamivudine and zidovudine in pharmaceutical formulations using the HPTLC method. Anal. Lett. 2009, 42:1552-1570.
12. Wankhede S.B., Gupta K.R., Tajne M.R., Wadodkar S.G. A validated HPTLC method for simultaneous estimation of lamivudine and zidovudine in tablets. Asian J. Chem. 2006, 19:2669-2672.
13. Agrawal H., Paradkar A.R., Mahadik K.R. The ICH guidance in practice: stress degradation studies on stavudine and development of a validated specific stability-indicating HPTLC assay method. J. Chromatogr. Sci. 2005, 48:406-415.
14. Anbazhagan S., Indumathy N., Shanmugapandiyan P., Sridhar S.K. Simultaneous quantification of stavudine, lamivudine and nevirapine by UV spectroscopy, reverse phase HPTLC and HPTLC in tablets. J. Pharm. Biomed. Anal. 2005, 39:801-804.
15. Guidelines Prepared within the International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human use (ICH), Validation of Analytical Procedure: Text and Methodology Q2 (R1) 2005, http://www.ich.org/, accessed on 24th July 2009, pp. 1-13.
16. Jahnke R.W.O. A concise quality control guide on essential drugs. Thin layer Chromatogr. 2001, II.
17. Touchstone J.C. Practice of Thin Layer Chromatography 1992, John Wiley & Sons, New York. 3rd ed.
18. Box G.E.P., Hunter W.G., Hunter J.S. An Introduction to Design, Data Analysis and Model Building 1978, J. Wiley, New York.
19. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., De Jong S., Lewi P.J., Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics: Part A 1997, Elsevier, Amsterdam.
20. Dejaegher B., Bloomfield M.S., Smeyers-Verbeke J., Vander Heyden Y. Validation of a fluorimetric assay for 4-aminophenol in paracetamol formulations. Talanta 2008, 75:258-265.
21. Vander Heyden Y., Nijhuis A., Smeyers-Verbeke J., Vandeginste B.G.M., Massart D.L. Guidance for robustness/ruggedness tests in method validation. J. Pharm. Biomed. Anal. 2001, 24:723-753.
22. The United States Pharmacopoeia 29 2006, National Formulary 24, United States, Pharmacopoeia Convention, Rockville, MD, USA.